Found: 20
Select item for more details and to access through your institution.
Proteasomal degradation of core protein variants from chronic hepatitis B patients.
- Published in:
- Journal of Medical Virology, 2007, v. 79, n. 9, p. 1312, doi. 10.1002/jmv.20939
- By:
- Publication type:
- Article
Stop Codon Insertion Restores the Particle Formation Ability of Hepatitis B Virus Core-Hantavirus Nucleocapsid Protein Fusions.
- Published in:
- Intervirology, 2002, v. 45, n. 4-6, p. 340, doi. 10.1159/000067927
- By:
- Publication type:
- Article
Evaluation of HBs, HBc, and frCP Virus-Like Particles for Expression of Human Papillomavirus 16 E7 Oncoprotein Epitopes.
- Published in:
- Intervirology, 2002, v. 45, n. 1, p. 24, doi. 10.1159/000050084
- By:
- Publication type:
- Article
RNA Phage Qβ Coat Protein as a Carrier for Foreign Epitopes.
- Published in:
- Intervirology, 1996, v. 39, n. 1/2, p. 9, doi. 10.1159/000150469
- By:
- Publication type:
- Article
Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.
- Published in:
- Virus Genes, 2007, v. 34, n. 3, p. 303, doi. 10.1007/s11262-006-0028-1
- By:
- Publication type:
- Article
Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114006
- By:
- Publication type:
- Article
A VLP Library of C-Terminally Truncated Hepatitis B Core Proteins: Correlation of RNA Encapsidation with a Th1/Th2 Switch in the Immune Responses of Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075938
- By:
- Publication type:
- Article
Versatile Virus-Like Particle Carrier for Epitope Based Vaccines.
- Published in:
- PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009809
- By:
- Publication type:
- Article
Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope.
- Published in:
- Biotechnology Journal, 2008, v. 3, n. 11, p. 1429, doi. 10.1002/biot.200800160
- By:
- Publication type:
- Article
PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine.
- Published in:
- Microorganisms, 2023, v. 11, n. 4, p. 972, doi. 10.3390/microorganisms11040972
- By:
- Publication type:
- Article
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.
- Published in:
- BMC Biotechnology, 2017, v. 17, p. 1, doi. 10.1186/s12896-017-0396-8
- By:
- Publication type:
- Article
Potato Virus M-Like Nanoparticles: Construction and Characterization.
- Published in:
- Molecular Biotechnology, 2015, v. 57, n. 11/12, p. 982, doi. 10.1007/s12033-015-9891-0
- By:
- Publication type:
- Article
The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
- Published in:
- Molecular Biotechnology, 2015, v. 57, n. 11/12, p. 1038, doi. 10.1007/s12033-015-9895-9
- By:
- Publication type:
- Article
Mosaic RNA Phage VLPs Carrying Domain III of the West Nile Virus E Protein.
- Published in:
- Molecular Biotechnology, 2014, v. 56, n. 5, p. 459, doi. 10.1007/s12033-014-9743-3
- By:
- Publication type:
- Article
Yeast-Expressed Bacteriophage-Like Particles for the Packaging of Nanomaterials.
- Published in:
- Molecular Biotechnology, 2014, v. 56, n. 2, p. 102, doi. 10.1007/s12033-013-9686-0
- By:
- Publication type:
- Article
Potato Virus Y-Like Particles as a New Carrier for the Presentation of Foreign Protein Stretches.
- Published in:
- Molecular Biotechnology, 2012, v. 52, n. 2, p. 129, doi. 10.1007/s12033-011-9480-9
- By:
- Publication type:
- Article
Formation of magnetoliposomes using self-assembling 1,4-dihydropyridine derivative and maghemite γ-FeO nanoparticles.
- Published in:
- Chemistry of Heterocyclic Compounds, 2015, v. 51, n. 7, p. 672, doi. 10.1007/s10593-015-1755-9
- By:
- Publication type:
- Article
Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
- Published in:
- Scientific Reports, 2015, p. 11639, doi. 10.1038/srep11639
- By:
- Publication type:
- Article
The True Story and Advantages of RNA Phage Capsids as Nanotools.
- Published in:
- Intervirology, 2016, v. 59, n. 2, p. 74, doi. 10.1159/000449503
- By:
- Publication type:
- Article
Posttranslational modifications and secretion efficiency of immunogenic hepatitis B virus L protein deletion variants.
- Published in:
- Virology Journal, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1743-422X-10-63
- By:
- Publication type:
- Article